Abstract
OVARIO, A Phase 2 Study of Niraparib + Bevacizumab in Advanced Ovarian Cancer Following Front-Line Platinum-Based Chemotherapy with Bevacizumab: Updated Analysis (039)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have